White Paper: Financing of Novel Therapeutics in Europe - Beyond Traditional Approaches (pdf)

This White Paper has been put together by the Boston Consulting Group, alongside with experts from a  range of major companies from the industry (Sanofi, Takeda, Pfizer, Janssen…).

During DIA EuroMeeting 2017, this White Paper will be discussed advanced with a broader set of health care stakeholders, and the outcome will be reported back to the EuroMeeting audience. Find out how we are going to answer burning questions around access to innovative treatments with new concepts!

Please enter your details below to receive the White Paper at your email address.